Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Return on Assets (2020 - 2025)

Historic Return on Assets for Benitec Biopharma (BNTC) over the last 6 years, with Q1 2025 value amounting to 0.37%.

  • Benitec Biopharma's Return on Assets rose 8100.0% to 0.37% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.37%, marking a year-over-year increase of 8100.0%. This contributed to the annual value of 0.76% for FY2024, which is 29000.0% up from last year.
  • Benitec Biopharma's Return on Assets amounted to 0.37% in Q1 2025, which was up 8100.0% from 0.32% recorded in Q4 2024.
  • Over the past 5 years, Benitec Biopharma's Return on Assets peaked at 0.32% during Q4 2024, and registered a low of 3.01% during Q2 2023.
  • In the last 5 years, Benitec Biopharma's Return on Assets had a median value of 1.09% in 2021 and averaged 1.17%.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -14500bps in 2022, then skyrocketed by 23700bps in 2024.
  • Over the past 5 years, Benitec Biopharma's Return on Assets (Quarter) stood at 1.09% in 2021, then decreased by -13bps to 1.23% in 2022, then rose by 27bps to 0.9% in 2023, then skyrocketed by 64bps to 0.32% in 2024, then dropped by -15bps to 0.37% in 2025.
  • Its Return on Assets was 0.37% in Q1 2025, compared to 0.32% in Q4 2024 and 0.35% in Q3 2024.